Target intelligence / Profile preview

High mobility group nucleosome binding domain 1 pseudogene 10 (HMGN1P10)

Target
HMGN1P10
Molecular classification
Pseudogene, Non-coding RNA (by extension; see below)
01

Overview

High mobility group nucleosome binding domain 1 pseudogene 10 (HMGN1P10) is a processed pseudogene annotated in the human genome. Pseudogenes are gene-derived DNA sequences that have lost the ability to produce functional proteins due to accumulated mutations. Most pseudogenes do not code for proteins but, in some cases, they may affect gene regulation at the RNA level, such as acting as competing endogenous RNAs or miRNA decoys; however, there is no evidence that HMGN1P10 has a confirmed regulatory role or biological function. It is not considered a therapeutic target or biomarker, and there are no known drugs or therapeutics that modulate this pseudogene. HMGN1P10 does not have any recognized involvement in human disease or cellular pathways beyond its annotation as a non-functional genomic element. Summary of Key Points: - HMGN1P10 is a pseudogene, not a protein, receptor, or enzyme. - It is not a drug target and does not play a confirmed functional role. - No interacting drugs, disease roles, or safety concerns are known. - It is primarily of genomic annotation interest, without clinical or pharmacological relevance.

Other names
HMGN1P10High mobility group nucleosome binding domain 1 pseudogene 10
02

Mechanism of action

Not applicable (as this is not a protein target)

03

Biological functions

No direct functional protein product.Some pseudogenes can have regulatory roles as non-coding RNAs (e.g., miRNA sponges, competing endogenous RNAs), but there is no evidence that HMGN1P10 specifically has such a function.No specific, confirmed biological function for HMGN1P10 itself in published literature or gene databases.
04

Disease associations

No disease association has been reported for HMGN1P10 specifically.Other HMGA/HMGN family pseudogenes, in general, can modulate expression of ancestral genes and have been implicated in cancer or metabolic diseases as regulatory RNAs; these are not established for HMGN1P10.

Beyond the preview

Go deeper on High mobility group nucleosome binding domain 1 pseudogene 10 (HMGN1P10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group nucleosome binding domain 1 pseudogene 10 (HMGN1P10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call